Abstract

2-deoxy-D-glucose, widely known as 2-DG, is a synthetic analogue of glucose that has biological effect on metabolic pathways – glycolysis and pentose phosphate pathway; on signalling pathways - 5′-AMP-activated kinase – AMPK, mammalian target of rapamycin complex 1 – mTORC1; and on biosynthesis of lipids and protein-N-glycosylation, thereby demonstrating its role as an anti-cancer, anti-inflammatory, calorie restriction mimetic, and anti-viral agent. Although the property of 2-DG as an anti-viral agent was widely known during the COVID-19 pandemic, its potential to inhibit influenza virus was evaluated for the first time in the year 1959. Subsequently, experimental studies pertaining to inhibition of viral infection by 2-DG was explored in viruses belonging to the family of Paramyxoviridae, Rhabdoviridae, Togaviridae, Herepesviridae, Flaviviridae, Adenoviridae and Retroviridae. The anti-viral potential of 2-DG in viruses experimented since the mid 1900s has been reviewed here in brief.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.